FGP
NBIX icon

Freestone Grove Partners’s Neurocrine Biosciences NBIX Stock Holding History

Freestone Grove Partners’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$21.1M Buy
168,133
+162,924
+3,128% +$20.5M 0.16% 193
2025
Q1 		$576K Buy
+5,209
New +$576K 0.01% 395